Neko Health, a Swedish health technology company co-founded by Spotify CEO Daniel Ek, has raised $700 million in a Series C funding round to support its expansion into the United States. The company, which specializes in non-invasive, preventive full-body scans, plans to open its first American clinic in New York City later this year. This latest investment values the startup at approximately $7 billion, marking a significant increase from its previous valuation of $1.7 billion in early 2025.
The company’s core offering is a 60-minute health assessment that uses proprietary sensors and blood analysis to capture millions of data points. These scans screen for early indicators of conditions such as skin cancer, heart disease, diabetes, and metabolic syndrome. Unlike traditional diagnostic centers, Neko Health operates a vertically integrated model, designing its own hardware, software, and clinical protocols in-house to maintain control over the patient experience.
Since its launch in 2023, Neko Health has gained traction in Europe, operating eight clinics across Sweden and the United Kingdom. According to the company, more than 100,000 people have completed a scan, and the service has attracted a waitlist of over 350,000 individuals. The company reports that a high percentage of members return for subsequent appointments, with many showing improvements in health markers over time.
The funding round was led by Lightspeed Venture Partners and O.G. Venture Partners, with participation from a wide range of investors including Mark Zuckerberg, Priscilla Chan, Maria Sharapova, and. Neko Health intends to use the capital to scale its research, develop new diagnostic capabilities, and accelerate its rollout of clinics across the U.S. and Europe. While the company has established a strong foothold in European markets, its entry into the U.S. represents its most significant geographic expansion to date.